click below
click below
Normal Size Small Size show me how
Endocrine 1
| Pharmacologic Category | Generic Name | Brand Name | Common Indications | Classification |
|---|---|---|---|---|
| Biguanide | metformin (PO) | Fortamet, Glumetza | Type 2 DM, PCOS | |
| Dipeptidyl peptidase inhibitor (DPP-4) | sitagliptan (PO) | Januvia, Zituvio | Type 2 DM | |
| Sodium-glucose cotransporter inhibitor 2 (SGLT2 inhibitor) | empagliflozin (PO) | Jardiance | Type 2 DM, HF, CKD | |
| Sodium-glucose co transporter inhibitor 2 (SGLT2 inhibitor) | dapagliflozin (PO) | Farxiga | Type 2 DM, HF, CKD | |
| Sulfonylurea | glimepiride (PO) | Amaryl | Type 2 DM | |
| Sulfonylurea | glipizide (PO) | Glucotrol, Glucotrol XL | Type 2 DM | |
| Thiazolidinedione (TZD) | pioglitazone (PO) | Actos | Type 2 DM | |
| Glucagon-like peptide-1 (GLP-1) receptor agonist | dulaglutide (SQ) | Trulicity | Type 2 DM | |
| Glucagon-like peptide-1 (GLP-1) receptor agonist | liraglutide (SQ) | Victoza, Saxenda | Type 2 DM, chronic weight management | |
| Glucagon-like peptide-1 (GLP-1) receptor agonist | semaglutide (PO,) | PO: Rybelsus | Type 2 DM, chronic weight management | |
| Glucagon-like peptide-1 (GLP-1) receptor agonist | semaglutide ( SQ) | SQ: Ozempic, Wegovy | Type 2 DM, chronic weight management | |
| Dual GLP-1 and glucose dependent insulinotropic polypeptide (GID) agonist | tirzepatide( SQ) | Mounjaro, Zepbound | Type 2 DM, chronic weight management | |
| Insulin, long acting | insulin glargine (SQ) | Lantus, Toujeo, Basaglar | Type 1 DM, Type 2 DM | |
| Insulin, intermediate acting | insulin NPH (SQ) | Humulin N, Novolin N | Type 1 DM, Type 2 DM | OTC |
| Insulin, rapid acting | insulin aspart (SQ) | Novolog | Type 1 DM, Type 2 DM | |
| Insulin, short-acting | insulin regular (SQ, IV) | Humulin R, Novolin R | Type 1 DM, Type 2 DM, DKA | SQ: OTC |